DIN 02518376 — LEQVIO 284 MG
LEQVIO is a solution of Inclisiran marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Inclisiran monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02518376
- Brand name
- LEQVIO
- Active ingredient
- Inclisiran
- Strength
- 284 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Small interfering RNA (siRNA) PCSK9 synthesis inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.